SCHEMBL1969399

SCHEMBL1969399

CCOC(=O)C(C)(C)c1ccc(C(O)CCCN2CCC(=C(c3ccccc3)c3ccccc3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.51
▸ HRH1 P35367 3/20 0.51
▸ DRD3 P35462 3/20 0.51
▸ KCNH2 Q12809 3/20 0.51
▸ HTR2A P28223 2/20 0.51
▸ HTR2B P41595 2/20 0.51
▸ BLM P54132 2/20 0.51
▸ CNR1 P21554 1/20 0.51
▸ APEX1 P27695 1/20 0.51
▸ PDE4A P27815 1/20 0.51
▸ PDE3A Q14432 1/20 0.51
▸ DRD2 P14416 2/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50
▸ OPRM1 P35372 2/20 0.46
▸ OPRK1 P41145 2/20 0.46
▸ OPRD1 P41143 2/20 0.46
▸ MEN1 O00255 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ CACNA1F O60840 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4580935 0.90 OPRM1 (0.44) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL1968862 0.88 LMNA (0.64) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL11382034 0.85 OPRK1 (0.50) LMNAHRH1DRD3KCNH2HTR2A
Hydrochloric Acid SCHEMBL11380464 0.84 OPRK1 (0.49) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL9075810 0.84 KCNH2 (0.61) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL6451132 0.82 HRH1 (0.59) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL10533239 0.81 HRH1 (0.47) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL11863099 0.81 HRH1 (0.56) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL6452266 0.81 KCNH2 (0.51) LMNAHRH1DRD3KCNH2HTR2A
SCHEMBL5999820 0.80 HRH1 (0.79) LMNAHRH1DRD3KCNH2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476445-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2013-07-02 — — US disclosed
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2011-12-01 — — US disclosed
US-8022220-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2011-09-20 — — US disclosed
EP-1958935-B1 Process for the production of terfenadine and carebastine derivatives with microorganisms ALBANY MOLECULAR RES INC (US) 2011-06-22 — — EP disclosed
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 — — US disclosed
US-7691615-B2 Process for the production of piperidine derivatives with microorganisms ALBANY MOLECULAR RESEARCH, INC. (US) 2010-04-06 — — US disclosed
US-7678915-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2010-03-16 — — US disclosed
US-20100010227-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 2010-01-14 — — US disclosed
US-7560561-B2 Process for production of piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 2009-07-14 — — US disclosed
EP-1339864-B1 PROCESS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES WITH MICROORGANISMS AMR TECHNOLOGY INC (US) 2008-12-31 — — EP disclosed
WO-1997023213-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES ALBANY MOLECULAR RESEARCH, INC. (US) 1997-07-03 — — WO disclosed
US-5589487-A Piperidine derivatives and process for their production ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-31 — — US disclosed
US-5581011-A Aromatic ketones and processes for their preparation ALBANY MOLECULAR RESEARCH, INC. (US) 1996-12-03 — — US disclosed
US-5578610-A Piperidine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-11-26 — — US disclosed
EP-0723958-A1 Synthesis of substantially pure terfenadine derivatives ALBANY MOLECULAR RESEARCH, INC. (US) 1996-07-31 — — EP disclosed
EP-0703902-A4 — ALBANY MOLECULAR RES INC (US) 1996-04-10 — — EP disclosed
EP-0703902-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1996-04-03 — — EP disclosed
WO-1995000482-A1 PIPERIDINE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION ALBANY MOLECULAR RESEARCH, INC. (US) 1995-01-05 — — WO disclosed
US-4285957-A ANTIALLERGENS; ANTIHISTAMINES; BRONCHODILATOR AGENTS RICHARDSON-MERRELL INC. (US) 1981-08-25 — — US disclosed
US-4254129-A ANTIALLERGENS, BRONCHODILATORS, ANTIHISTAMINES; 4-DIPHENYLMETHYL PIPERIDINO-ALKANOLS RICHARDSON-MERRELL INC. (US) 1981-03-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110295014-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES OR10J3, NR1H2, NR1H3 LMNA 4284/4885HRH1 313/4885DRD3 448/4885
US-20100137605-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES HPD, PTMA, HAAO LMNA 2264/4885HRH1 727/4885DRD3 687/4885
US-20100010227-A1 PROCESS FOR PRODUCTION OF PIPERIDINE DERIVATIVES DDC, HPD, ALDH7A1 LMNA 2378/4885HRH1 882/4885DRD3 933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback